Total ovarian volume before human chorionic gonadotrophin administration for ovulation induction may predict the hyperstimulation syndrome

被引:15
作者
Oyesanya, OA
Parsons, JH
Collins, WP
Campbell, S
机构
[1] Academic Department of Obstetrics and Gynaecology, King's College School of Medicine and Dentistry, London SE5 8RX, Denmark Hill
关键词
IVF; ovarian growth factors; ovarian hyperstimulation syndrome; prediction; total ovarian volumes;
D O I
10.1093/oxfordjournals.humrep.a135890
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Total ovarian volumes were measured before the administration of HCG in 42 women undergoing treatment for infertility by in-vitro fertilization (IVF) and embryo transfer and considered to have an exaggerated response to stimulation (>20 follicles). Seven women who subsequently developed moderate or severe ovarian hyperstimulation syndrome (OHSS) (n = 7; group 1) were compared with 35 matched controls (five matched controls per case; n = 35; group 2) of similar age, number of follicles and duration of infertility who underwent follicular stimulation, oocyte recovery, in-vitro fertilization and embryo transfer during the same period but did not develop moderate or severe OHSS. The mean age, duration of infertility and total number of follicles were similar but the mean total ovarian volume was significantly higher in the group of women who developed moderate or severe OHSS compared with controls (271.00 +/- 87.00 versus 157.30 +/- 54.20 mi; P < 0.01), We conclude that total ovarian volume measured before HCG administration is higher in women who develop moderate or severe OHSS compared with controls and may therefore be used as an additional parameter in the preventative strategy for the ovarian hyperstimulation syndrome.
引用
收藏
页码:3211 / 3212
页数:2
相关论文
共 9 条
[1]  
ADAMS J, 1985, LANCET, V2, P1375
[2]  
FORMAN RG, 1990, FERTIL STERIL, V53, P502
[3]   ULTRASONIC CONTROL WITHOUT HORMONE DETERMINATION FOR OVULATION INDUCTION IN IN-VITRO FERTILIZATION-EMBRYO TRANSFER WITH GONADOTROPIN-RELEASING-HORMONE ANALOG AND HUMAN MENOPAUSAL GONADOTROPIN [J].
GOLAN, A ;
HERMAN, A ;
SOFFER, Y ;
BUKOVSKY, I ;
RONEL, R .
HUMAN REPRODUCTION, 1994, 9 (09) :1631-1633
[4]  
Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004
[5]  
LYONS CAD, 1994, HUM REPROD, V9, P792
[6]   PITUITARY DOWN-REGULATION PRIOR TO IN-VITRO FERTILIZATION AND EMBRYO-TRANSFER - A COMPARISON BETWEEN A SINGLE-DOSE OF ZOLADEX DEPOT AND MULTIPLE DAILY DOSES OF SUPREFACT [J].
OYESANYA, OA ;
TEO, SK ;
QUAH, E ;
ABDURAZAK, N ;
LEE, FY ;
CHENG, WC .
HUMAN REPRODUCTION, 1995, 10 (05) :1042-1044
[7]   HUMAN MENOPAUSAL GONADOTROPINS FOR ANOVULATION AND STERILITY - RESULTS OF 7 YEARS OF TREATMENT [J].
RABAU, E ;
DAVID, A ;
SERR, DM ;
MASCHIAC.S ;
LUNENFELD, B .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1967, 98 (01) :92-+
[8]   OVARIAN HYPERSTIMULATION SYNDROME AFTER SUPEROVULATION USING GNRH AGONISTS FOR IVF AND RELATED PROCEDURES [J].
RIZK, B ;
SMITZ, J .
HUMAN REPRODUCTION, 1992, 7 (03) :320-327
[9]   A SIMPLE METHOD FOR EVALUATING THE SHAPIRO-FRANCIA W TEST OF NON-NORMALITY [J].
ROYSTON, JP .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 1983, 32 (03) :297-300